Whitehawk Therapeutics (AADI) Q3 2023 Earnings

8NovConfirmed
Nov 22
Q1 2023
Q2 2023
Q3 2023
-0.74
-0.68
-0.63
-0.57

Details

Expected EPS
-0.72
Actual EPS
-0.6
Surprise EPS
0.12
Surprise Percent
+16.67%

Description

Whitehawk Therapeutics (AADI) has reported earnings of -0.6 per share for Q3 2023.

0 Comments

Share your thoughts